NorthRock Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,917
Closed -$444K 742
2025
Q3
$444K Buy
5,917
+2,094
+55% +$156K 0.01% 568
2025
Q2
$283K Sell
3,823
-2,757
-42% -$192K 0.01% 550
2025
Q1
$531K Buy
6,580
+327
+5% +$28.1K 0.02% 337
2024
Q4
$489K Sell
6,253
-551
-8% -$46.8K 0.02% 362
2024
Q3
$639K Buy
6,804
+356
+6% +$29.9K 0.02% 308
2024
Q2
$502K Buy
6,448
+167
+3% +$13.6K 0.02% 342
2024
Q1
$571K Buy
6,281
+41
+0.7% +$3.41K 0.02% 323
2023
Q4
$482K Buy
6,240
+2,325
+59% +$163K 0.02% 329
2023
Q3
$266K Buy
3,915
+1,133
+41% +$82.4K 0.03% 263
2023
Q2
$226K Buy
+2,782
New +$222K 0.02% 268

Other funds holding GEHC

NorthRock Partners's GEHC Position: Q4 2025 in Review

NorthRock Partners sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 5,917 shares — an estimated $444K sold.

NorthRock Partners first reported a position in GEHC in Q2 2023 and held it in 10 quarters. The position peaked at $639K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

  • NorthRock Partners reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
  • NorthRock Partners sold 5,917 GE HealthCare shares in Q4 2025, an estimated $444K.
  • NorthRock Partners first reported a position in GE HealthCare in Q2 2023 and held it in 10 quarters.
  • NorthRock Partners's GE HealthCare position peaked at $639K in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.